Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 30, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-906 Oral Capsule

TAK-906 capsule.

DRUG

[14C]-TAK-906 Intravenous Infusion

\[14C\]-TAK-906 intravenous infusion.

DRUG

[14C]-TAK-906 Oral Solution

\[14C\]-TAK-906 oral solution.

Trial Locations (1)

Celerion, Lincoln